Effect of Endothelial Adhesion Molecules on Atrial Fibrillation: A Systematic Review and Meta-analysis [0.03%]
血管内皮粘附分子对房颤影响的系统评价和 meta 分析
Mehran Rahimi,Leili Faridi,Leila Nikniaz et al.
Mehran Rahimi et al.
Background: Endothelial adhesion molecules (EAMs), and more specifically vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), belong to a family of immunoglobulin-like molecules and are found to have in...
Strategies for Reducing Vascular and Bleeding Risk for Percutaneous Left Ventricular Assist Device-supported High-risk Percutaneous Coronary Intervention [0.03%]
经皮左心室辅助装置支持下的高危冠脉介入治疗降低血管和出血风险的策略
George W Vetrovec,Amir Kaki,Jason Wollmuth et al.
George W Vetrovec et al.
In patients at high risk for haemodynamic instability during percutaneous coronary intervention (PCI), practitioners are increasingly opting for prophylactic mechanical circulatory support, such as the Impella® heart pump (Abiomed, Danvers...
Saad M Ezad,Matthew Ryan,Divaka Perera
Saad M Ezad
Coronary artery disease (CAD) remains the most common cause of heart failure with reduced ejection fraction; despite its prevalence, there is limited evidence to guide physicians in managing patients with CAD with percutaneous revasculariza...
Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management [0.03%]
vasospastic心绞痛的病理生理、诊断和治疗的当代综述
Aish Sinha,Haseeb Rahman,Divaka Perera
Aish Sinha
Nearly 40% of patients presenting to the catheter laboratory with angina have non-obstructed coronary arteries (ANOCA), an umbrella term that encompasses distinct pathophysiological entities, such as coronary artery spasm. Coronary artery s...
Yu Horiuchi,Humberto Villacorta,Alan S Maisel
Yu Horiuchi
Heart failure (HF) is a complex syndrome with high mortality and hospitalization rates. Conventional care in patients with HF is usually based on clinical history and physical examination. Natriuretic peptides (NPs), B-type NP (BNP) and N-t...
Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy [0.03%]
莫司卡替尼：一类首次口服型心脏肌球蛋白调节剂，用于治疗症状性肥厚梗阻性心肌病
Klevin Roger L Reyes,Gizem Bilgili,Florian Rader
Klevin Roger L Reyes
Hypertrophic cardiomyopathy is the most common monogenic cardiovascular disease that is caused by sarcomeric protein gene mutations. A hallmark of the most common form of the disease is outflow obstruction secondary to systolic narrowing of...
A Review of the Past, Present and Future of Cancer-associated Thrombosis Management [0.03%]
肿瘤相关血栓防治的过去、现在和未来综述
Randy K Ramcharitar,Louise Man,Minhaj S Khaja et al.
Randy K Ramcharitar et al.
Venous thromboembolism (VTE) can have a significant impact on the management, quality of life and mortality of patients with cancer. VTE occurs in 5-20% of patients with cancer, and malignancy is associated with up to 25% of all VTE. It is ...
Coronary Revascularization and Out-of-hospital Cardiac Arrest: Past, Present and Future [0.03%]
冠脉血运重建与院外心脏骤停：过去、现在和未来
Matthew E Li Kam Wa,Kalpa De Silva,Nilesh Pareek et al.
Matthew E Li Kam Wa et al.
Cardiologists and the cardiac catheter laboratory have key roles to play in the management of patients after out-of-hospital cardiac arrest (OHCA). Although immediate catheter laboratory activation is the standard of care in cardiogenic sho...
An Unusual Cause of Pacemaker Lead Displacement: 'Reverse Ratchet' Syndrome [0.03%]
起搏器导线移位的不寻常原因：“反向棘轮”综合征
Haytham Enab,Colin Cunnington,Amir Zaidi
Haytham Enab
Lead displacement is a common complication of pacemaker device implantation, often resulting in prolonged hospital stays and increased costs. The frequency of long-term lead displacement ranges between 1.8% and 8.0%. In our case, the patien...
A Narrative Review of Ultrathin-strut Drug-eluting Stents: The Thinner the Better? [0.03%]
超薄 strut 药物洗脱支架：越薄越好？一项叙述性研究
Maik J Grundeken,Marcel Am Beijk
Maik J Grundeken
Second-generation drug-eluting stents (DES) are considered standard of care for revascularization of patients undergoing percutaneous coronary intervention. Besides the polymer and antiproliferative drug used, the metallic backbone of DES i...